Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.97322281 |
2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.52957719 |
3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.43338410 |
4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.43338410 |
5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.43338410 |
6 | modulation by symbiont of host immune response (GO:0052553) | 4.43338410 |
7 | positive regulation by symbiont of host defense response (GO:0052509) | 4.43338410 |
8 | modulation by symbiont of host defense response (GO:0052031) | 4.43338410 |
9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.25348443 |
10 | negative regulation of cell killing (GO:0031342) | 4.25348443 |
11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.95105550 |
12 | response to peptidoglycan (GO:0032494) | 3.87864329 |
13 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.81113368 |
14 | mannose metabolic process (GO:0006013) | 3.74798138 |
15 | response to muramyl dipeptide (GO:0032495) | 3.73973915 |
16 | modulation by virus of host process (GO:0019054) | 3.71102973 |
17 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.67582271 |
18 | leukocyte aggregation (GO:0070486) | 3.65768642 |
19 | positive thymic T cell selection (GO:0045059) | 3.60640617 |
20 | modulation by symbiont of host cellular process (GO:0044068) | 3.58796641 |
21 | macrophage activation involved in immune response (GO:0002281) | 3.53576944 |
22 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.39422664 |
23 | regulation of gamma-delta T cell activation (GO:0046643) | 3.39354660 |
24 | detection of bacterium (GO:0016045) | 3.39138333 |
25 | detection of other organism (GO:0098543) | 3.33942453 |
26 | NIK/NF-kappaB signaling (GO:0038061) | 3.33868349 |
27 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.33289079 |
28 | thymic T cell selection (GO:0045061) | 3.31088242 |
29 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.24483491 |
30 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.21918216 |
31 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.18600705 |
32 | ribosomal small subunit biogenesis (GO:0042274) | 3.15039944 |
33 | negative regulation of phagocytosis (GO:0050765) | 3.01849460 |
34 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.01226405 |
35 | response to laminar fluid shear stress (GO:0034616) | 3.01015667 |
36 | apoptotic process involved in morphogenesis (GO:0060561) | 2.99315339 |
37 | T cell selection (GO:0045058) | 2.91641100 |
38 | negative regulation of granulocyte differentiation (GO:0030853) | 2.87528417 |
39 | regulation of leukocyte degranulation (GO:0043300) | 2.86709998 |
40 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.86373198 |
41 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.85838007 |
42 | positive regulation of B cell differentiation (GO:0045579) | 2.85674712 |
43 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.83738852 |
44 | tolerance induction (GO:0002507) | 2.82675946 |
45 | neutrophil activation involved in immune response (GO:0002283) | 2.82239271 |
46 | B cell receptor signaling pathway (GO:0050853) | 2.81042593 |
47 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.79009707 |
48 | response to host (GO:0075136) | 2.79009707 |
49 | response to host defenses (GO:0052200) | 2.79009707 |
50 | negative regulation of interleukin-12 production (GO:0032695) | 2.78273388 |
51 | cellular extravasation (GO:0045123) | 2.77752692 |
52 | response to host immune response (GO:0052572) | 2.77697111 |
53 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.77697111 |
54 | viral transcription (GO:0019083) | 2.76695830 |
55 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.74908864 |
56 | immunoglobulin mediated immune response (GO:0016064) | 2.74587333 |
57 | positive T cell selection (GO:0043368) | 2.73254235 |
58 | stress fiber assembly (GO:0043149) | 2.69576337 |
59 | regulation of defense response to virus by virus (GO:0050690) | 2.69352111 |
60 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.69065423 |
61 | regulation of mast cell degranulation (GO:0043304) | 2.68458200 |
62 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.67518114 |
63 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.67415279 |
64 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.66133797 |
65 | negative thymic T cell selection (GO:0045060) | 2.65753300 |
66 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.64543849 |
67 | germinal center formation (GO:0002467) | 2.63672369 |
68 | regulation of early endosome to late endosome transport (GO:2000641) | 2.63302843 |
69 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.62711591 |
70 | negative regulation of glial cell proliferation (GO:0060253) | 2.61234897 |
71 | detection of external biotic stimulus (GO:0098581) | 2.59155014 |
72 | cellular response to virus (GO:0098586) | 2.58474437 |
73 | negative regulation of viral release from host cell (GO:1902187) | 2.57655884 |
74 | activation of MAPKKK activity (GO:0000185) | 2.57362420 |
75 | regulation of granulocyte differentiation (GO:0030852) | 2.56699679 |
76 | regulation of chromatin binding (GO:0035561) | 2.56276456 |
77 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.55758052 |
78 | Peyers patch development (GO:0048541) | 2.55001748 |
79 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.55001748 |
80 | regulation of monocyte differentiation (GO:0045655) | 2.54225834 |
81 | pentose-phosphate shunt (GO:0006098) | 2.53766983 |
82 | respiratory burst (GO:0045730) | 2.52311532 |
83 | positive regulation of histone deacetylation (GO:0031065) | 2.50989295 |
84 | embryonic process involved in female pregnancy (GO:0060136) | 2.50659862 |
85 | histone H4 deacetylation (GO:0070933) | 2.50463938 |
86 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.50327838 |
87 | negative regulation of innate immune response (GO:0045824) | 2.48993151 |
88 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.46878743 |
89 | negative T cell selection (GO:0043383) | 2.46843133 |
90 | negative regulation of interleukin-6 production (GO:0032715) | 2.44340937 |
91 | modulation by virus of host morphology or physiology (GO:0019048) | 2.43396076 |
92 | T cell homeostasis (GO:0043029) | 2.41874255 |
93 | negative regulation of cell size (GO:0045792) | 2.40645475 |
94 | signal complex assembly (GO:0007172) | 2.37370433 |
95 | translational termination (GO:0006415) | 2.36488323 |
96 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.36343072 |
97 | negative regulation of interleukin-8 production (GO:0032717) | 2.36318709 |
98 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.36199241 |
99 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.36150639 |
100 | pinocytosis (GO:0006907) | 2.35961930 |
Rank | Gene Set | Z-score |
---|---|---|
1 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.62045891 |
2 | MYC_22102868_ChIP-Seq_BL_Human | 3.31662734 |
3 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.64747544 |
4 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.60512899 |
5 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.53159125 |
6 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.51108058 |
7 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.45648432 |
8 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.42029001 |
9 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.34287698 |
10 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.34209259 |
11 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.27549967 |
12 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.22165268 |
13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.17886143 |
14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.00046519 |
15 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.99907612 |
16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.95792502 |
17 | MAF_26560356_Chip-Seq_TH1_Human | 1.91901568 |
18 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.90941559 |
19 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.89859698 |
20 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.85281462 |
21 | UTX_26944678_Chip-Seq_JUKART_Human | 1.82720963 |
22 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.81469852 |
23 | MAF_26560356_Chip-Seq_TH2_Human | 1.79910916 |
24 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.75686162 |
25 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.70853630 |
26 | KDM2B_26808549_Chip-Seq_K562_Human | 1.66406424 |
27 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.66251855 |
28 | P68_20966046_ChIP-Seq_HELA_Human | 1.66225612 |
29 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.65717640 |
30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63862511 |
31 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.63472388 |
32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.60214012 |
33 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.59545381 |
34 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.55734529 |
35 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.54269167 |
36 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.53563569 |
37 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.52738517 |
38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.52674854 |
39 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.48737675 |
40 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.47168937 |
41 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.46894125 |
42 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.45852746 |
43 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.43572297 |
44 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.41717076 |
45 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.40084250 |
46 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.39023930 |
47 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.37428667 |
48 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.37216388 |
49 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.36107806 |
50 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34702113 |
51 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.30471211 |
52 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.30450597 |
53 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29984488 |
54 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.29734797 |
55 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.29521517 |
56 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.28140893 |
57 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.28016066 |
58 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.27151745 |
59 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27015700 |
60 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.26616826 |
61 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.25790283 |
62 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.24891314 |
63 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.24661648 |
64 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.23005664 |
65 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.22951060 |
66 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.19242574 |
67 | SPI1_23127762_ChIP-Seq_K562_Human | 1.18592873 |
68 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.17704971 |
69 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.17679510 |
70 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.17344630 |
71 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.17321581 |
72 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.16960325 |
73 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.14545897 |
74 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.14026073 |
75 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.13797952 |
76 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.13232915 |
77 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13152613 |
78 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.12759430 |
79 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.12594226 |
80 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.12462582 |
81 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.11528975 |
82 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.11512820 |
83 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09428519 |
84 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.08274092 |
85 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.08023426 |
86 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07987185 |
87 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06736641 |
88 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05652982 |
89 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.05323603 |
90 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.05041266 |
91 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04798082 |
92 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.04551151 |
93 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04394965 |
94 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.04351838 |
95 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.03670281 |
96 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.03192381 |
97 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.02686265 |
98 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.02308083 |
99 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01036983 |
100 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00122579 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003303_peritoneal_inflammation | 4.25578750 |
2 | MP0003436_decreased_susceptibility_to | 3.67990681 |
3 | MP0005058_abnormal_lysosome_morphology | 3.06697861 |
4 | MP0009278_abnormal_bone_marrow | 3.00519052 |
5 | MP0003172_abnormal_lysosome_physiology | 2.69071217 |
6 | MP0008260_abnormal_autophagy | 2.62017989 |
7 | MP0003763_abnormal_thymus_physiology | 2.47361757 |
8 | MP0003705_abnormal_hypodermis_morpholog | 2.41186971 |
9 | MP0009333_abnormal_splenocyte_physiolog | 2.26466778 |
10 | MP0005451_abnormal_body_composition | 2.26065613 |
11 | MP0003300_gastrointestinal_ulcer | 2.19768843 |
12 | MP0005025_abnormal_response_to | 2.14565134 |
13 | MP0002419_abnormal_innate_immunity | 2.14153260 |
14 | MP0003724_increased_susceptibility_to | 2.09094117 |
15 | MP0005000_abnormal_immune_tolerance | 2.03468753 |
16 | MP0004185_abnormal_adipocyte_glucose | 2.02402332 |
17 | MP0001800_abnormal_humoral_immune | 2.02177807 |
18 | MP0003191_abnormal_cellular_cholesterol | 2.01856771 |
19 | MP0001835_abnormal_antigen_presentation | 1.95855299 |
20 | MP0009840_abnormal_foam_cell | 1.95272842 |
21 | MP0000685_abnormal_immune_system | 1.94475639 |
22 | MP0005387_immune_system_phenotype | 1.90501785 |
23 | MP0001790_abnormal_immune_system | 1.90501785 |
24 | MP0005076_abnormal_cell_differentiation | 1.89758337 |
25 | MP0002420_abnormal_adaptive_immunity | 1.88340552 |
26 | MP0001819_abnormal_immune_cell | 1.85979608 |
27 | MP0002723_abnormal_immune_serum | 1.81343538 |
28 | MP0002398_abnormal_bone_marrow | 1.77037718 |
29 | MP0002452_abnormal_antigen_presenting | 1.76461988 |
30 | MP0001545_abnormal_hematopoietic_system | 1.72338628 |
31 | MP0005397_hematopoietic_system_phenotyp | 1.72338628 |
32 | MP0004947_skin_inflammation | 1.71798633 |
33 | MP0001849_ear_inflammation | 1.70512086 |
34 | MP0005464_abnormal_platelet_physiology | 1.70211748 |
35 | MP0000703_abnormal_thymus_morphology | 1.66869531 |
36 | MP0002396_abnormal_hematopoietic_system | 1.66386615 |
37 | MP0001533_abnormal_skeleton_physiology | 1.66144946 |
38 | MP0003183_abnormal_peptide_metabolism | 1.61691465 |
39 | MP0002405_respiratory_system_inflammati | 1.60979902 |
40 | MP0000716_abnormal_immune_system | 1.57944612 |
41 | MP0005409_darkened_coat_color | 1.54696189 |
42 | MP0004381_abnormal_hair_follicle | 1.50335487 |
43 | MP0005666_abnormal_adipose_tissue | 1.41796156 |
44 | MP0001873_stomach_inflammation | 1.40922186 |
45 | MP0004510_myositis | 1.39549938 |
46 | MP0004858_abnormal_nervous_system | 1.39467932 |
47 | MP0002429_abnormal_blood_cell | 1.39447239 |
48 | MP0000858_altered_metastatic_potential | 1.39425525 |
49 | MP0002722_abnormal_immune_system | 1.38102702 |
50 | MP0000678_abnormal_parathyroid_gland | 1.34711748 |
51 | MP0004808_abnormal_hematopoietic_stem | 1.33935506 |
52 | MP0010155_abnormal_intestine_physiology | 1.33571100 |
53 | MP0003453_abnormal_keratinocyte_physiol | 1.30136155 |
54 | MP0003123_paternal_imprinting | 1.30041726 |
55 | MP0005671_abnormal_response_to | 1.28683543 |
56 | MP0000689_abnormal_spleen_morphology | 1.25746698 |
57 | MP0009785_altered_susceptibility_to | 1.23866193 |
58 | MP0002132_abnormal_respiratory_system | 1.23667567 |
59 | MP0000490_abnormal_crypts_of | 1.20636411 |
60 | MP0003828_pulmonary_edema | 1.20580620 |
61 | MP0000465_gastrointestinal_hemorrhage | 1.18460875 |
62 | MP0001851_eye_inflammation | 1.18298298 |
63 | MP0009379_abnormal_foot_pigmentation | 1.18080770 |
64 | MP0002148_abnormal_hypersensitivity_rea | 1.17414161 |
65 | MP0005310_abnormal_salivary_gland | 1.15936015 |
66 | MP0002998_abnormal_bone_remodeling | 1.12079666 |
67 | MP0001845_abnormal_inflammatory_respons | 1.08864208 |
68 | MP0003091_abnormal_cell_migration | 1.08095078 |
69 | MP0006082_CNS_inflammation | 1.07035188 |
70 | MP0002877_abnormal_melanocyte_morpholog | 1.06895888 |
71 | MP0003866_abnormal_defecation | 1.06389618 |
72 | MP0001663_abnormal_digestive_system | 1.05821079 |
73 | MP0001853_heart_inflammation | 1.00455381 |
74 | MP0005390_skeleton_phenotype | 0.99146489 |
75 | MP0003075_altered_response_to | 0.99114777 |
76 | MP0000015_abnormal_ear_pigmentation | 0.97137928 |
77 | MP0005375_adipose_tissue_phenotype | 0.95992358 |
78 | MP0004233_abnormal_muscle_weight | 0.93848440 |
79 | MP0003279_aneurysm | 0.89280578 |
80 | MP0008469_abnormal_protein_level | 0.87472660 |
81 | MP0005381_digestive/alimentary_phenotyp | 0.86122234 |
82 | MP0003566_abnormal_cell_adhesion | 0.86075737 |
83 | MP0004130_abnormal_muscle_cell | 0.85668759 |
84 | MP0003329_amyloid_beta_deposits | 0.85258019 |
85 | MP0001348_abnormal_lacrimal_gland | 0.84253458 |
86 | MP0002796_impaired_skin_barrier | 0.81470543 |
87 | MP0003448_altered_tumor_morphology | 0.80667215 |
88 | MP0009931_abnormal_skin_appearance | 0.80074825 |
89 | MP0000604_amyloidosis | 0.76930456 |
90 | MP0005075_abnormal_melanosome_morpholog | 0.74793458 |
91 | MP0002089_abnormal_postnatal_growth/wei | 0.74415991 |
92 | MP0000733_abnormal_muscle_development | 0.72322408 |
93 | MP0002138_abnormal_hepatobiliary_system | 0.71085834 |
94 | MP0002249_abnormal_larynx_morphology | 0.70715143 |
95 | MP0003656_abnormal_erythrocyte_physiolo | 0.68593965 |
96 | MP0002933_joint_inflammation | 0.67114228 |
97 | MP0005501_abnormal_skin_physiology | 0.66397864 |
98 | MP0005621_abnormal_cell_physiology | 0.65903793 |
99 | MP0000681_abnormal_thyroid_gland | 0.65666665 |
100 | MP0009115_abnormal_fat_cell | 0.63757816 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 4.67595899 |
2 | Cellulitis (HP:0100658) | 3.64675335 |
3 | Abnormality of macrophages (HP:0004311) | 3.33637512 |
4 | Recurrent abscess formation (HP:0002722) | 3.32918049 |
5 | Recurrent bacterial skin infections (HP:0005406) | 3.31392940 |
6 | Obstructive lung disease (HP:0006536) | 3.27592300 |
7 | Chronic obstructive pulmonary disease (HP:0006510) | 3.27592300 |
8 | Increased IgE level (HP:0003212) | 2.95734699 |
9 | Mediastinal lymphadenopathy (HP:0100721) | 2.70679087 |
10 | Meningitis (HP:0001287) | 2.67560730 |
11 | Gastrointestinal inflammation (HP:0004386) | 2.59620806 |
12 | Colitis (HP:0002583) | 2.58691322 |
13 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.58037547 |
14 | Gingivitis (HP:0000230) | 2.57087045 |
15 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.52717847 |
16 | Recurrent fungal infections (HP:0002841) | 2.52219214 |
17 | Agammaglobulinemia (HP:0004432) | 2.49453732 |
18 | Obstructive sleep apnea (HP:0002870) | 2.47495015 |
19 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.47337380 |
20 | Hypertensive crisis (HP:0100735) | 2.45078225 |
21 | Myositis (HP:0100614) | 2.39845379 |
22 | Gastrointestinal stroma tumor (HP:0100723) | 2.38819340 |
23 | Dysostosis multiplex (HP:0000943) | 2.37823893 |
24 | Recurrent viral infections (HP:0004429) | 2.37165577 |
25 | Purpura (HP:0000979) | 2.35308039 |
26 | Prolonged bleeding time (HP:0003010) | 2.31812994 |
27 | Polygenic inheritance (HP:0010982) | 2.31599698 |
28 | Hyperacusis (HP:0010780) | 2.28325337 |
29 | Increased cerebral lipofuscin (HP:0011813) | 2.26720961 |
30 | Inflammation of the large intestine (HP:0002037) | 2.26306644 |
31 | Deep palmar crease (HP:0006191) | 2.26127771 |
32 | Increased serum ferritin (HP:0003281) | 2.24190503 |
33 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.20334357 |
34 | Panhypogammaglobulinemia (HP:0003139) | 2.19116285 |
35 | Spontaneous hematomas (HP:0007420) | 2.18912696 |
36 | Neonatal hypoglycemia (HP:0001998) | 2.18655030 |
37 | Hypercortisolism (HP:0001578) | 2.17262368 |
38 | Vertebral compression fractures (HP:0002953) | 2.15564895 |
39 | Abnormality of the fingertips (HP:0001211) | 2.15072973 |
40 | Abnormality of the thoracic spine (HP:0100711) | 2.14874741 |
41 | Broad face (HP:0000283) | 2.14455318 |
42 | Annular pancreas (HP:0001734) | 2.14206228 |
43 | Thoracic kyphosis (HP:0002942) | 2.12665189 |
44 | Disproportionate tall stature (HP:0001519) | 2.08072585 |
45 | Loss of speech (HP:0002371) | 2.06990605 |
46 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.06899912 |
47 | Petechiae (HP:0000967) | 2.06569055 |
48 | Vasculitis (HP:0002633) | 2.06269091 |
49 | Hypochromic anemia (HP:0001931) | 2.04693918 |
50 | Slow saccadic eye movements (HP:0000514) | 2.03967411 |
51 | Gastrointestinal infarctions (HP:0005244) | 2.03656723 |
52 | Thin bony cortex (HP:0002753) | 2.03178164 |
53 | Long palpebral fissure (HP:0000637) | 2.03064204 |
54 | Abnormality of the nasal mucosa (HP:0000433) | 2.02474921 |
55 | Recurrent skin infections (HP:0001581) | 2.00700585 |
56 | Nasal polyposis (HP:0100582) | 2.00089043 |
57 | Seborrheic dermatitis (HP:0001051) | 1.98267518 |
58 | Mitral regurgitation (HP:0001653) | 1.97350621 |
59 | Orchitis (HP:0100796) | 1.96235537 |
60 | Papilloma (HP:0012740) | 1.96125054 |
61 | Verrucae (HP:0200043) | 1.96125054 |
62 | Urticaria (HP:0001025) | 1.95961831 |
63 | Hemorrhage of the eye (HP:0011885) | 1.95637438 |
64 | Anomalous pulmonary venous return (HP:0010772) | 1.94827973 |
65 | Hyperthyroidism (HP:0000836) | 1.93232993 |
66 | Truncus arteriosus (HP:0001660) | 1.93085375 |
67 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.92348635 |
68 | Osteomyelitis (HP:0002754) | 1.92247069 |
69 | Peripheral hypomyelination (HP:0007182) | 1.91037759 |
70 | Viral hepatitis (HP:0006562) | 1.90371475 |
71 | Easy fatigability (HP:0003388) | 1.90164105 |
72 | Emphysema (HP:0002097) | 1.89243994 |
73 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.88241056 |
74 | Abnormality of the pulmonary veins (HP:0011718) | 1.88181054 |
75 | Epistaxis (HP:0000421) | 1.86298891 |
76 | Pustule (HP:0200039) | 1.86053833 |
77 | Lymphopenia (HP:0001888) | 1.85507357 |
78 | Metaphyseal cupping (HP:0003021) | 1.85010036 |
79 | Supranuclear gaze palsy (HP:0000605) | 1.84060668 |
80 | Recurrent cutaneous fungal infections (HP:0011370) | 1.82848698 |
81 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.82848698 |
82 | Microvesicular hepatic steatosis (HP:0001414) | 1.81738562 |
83 | Chest pain (HP:0100749) | 1.80126083 |
84 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.80047116 |
85 | Achilles tendon contracture (HP:0001771) | 1.79727334 |
86 | Atelectasis (HP:0100750) | 1.78674557 |
87 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.77390565 |
88 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.77390565 |
89 | Abnormality of glycolipid metabolism (HP:0010969) | 1.77390565 |
90 | Amyloidosis (HP:0011034) | 1.77124680 |
91 | Thrombocytosis (HP:0001894) | 1.76900610 |
92 | Hypergammaglobulinemia (HP:0010702) | 1.76899755 |
93 | Restrictive lung disease (HP:0002091) | 1.76872858 |
94 | Increased variability in muscle fiber diameter (HP:0003557) | 1.76461463 |
95 | Sepsis (HP:0100806) | 1.76118838 |
96 | Neuronal loss in central nervous system (HP:0002529) | 1.74606866 |
97 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.74414190 |
98 | Hyperparathyroidism (HP:0000843) | 1.74218452 |
99 | Polycythemia (HP:0001901) | 1.73495925 |
100 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.71922899 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIB3 | 4.33382002 |
2 | PRPF4B | 3.63134456 |
3 | ERN1 | 3.44729431 |
4 | SMG1 | 3.07478201 |
5 | MAP4K1 | 2.61390486 |
6 | ICK | 2.57624222 |
7 | SIK1 | 2.48572744 |
8 | MAP2K3 | 2.07401436 |
9 | MAP3K10 | 2.03394719 |
10 | RIPK4 | 1.99461832 |
11 | IRAK3 | 1.95499281 |
12 | CDK12 | 1.93920208 |
13 | NME2 | 1.92100716 |
14 | TYK2 | 1.75731513 |
15 | IRAK4 | 1.74001163 |
16 | TESK2 | 1.69740463 |
17 | MAP3K13 | 1.61128597 |
18 | MAP3K11 | 1.56941087 |
19 | MARK2 | 1.42905617 |
20 | TAOK1 | 1.41174072 |
21 | ZAP70 | 1.40886167 |
22 | ARAF | 1.39863149 |
23 | TNK2 | 1.36273529 |
24 | EEF2K | 1.32089260 |
25 | TAOK2 | 1.31348322 |
26 | SIK2 | 1.27827651 |
27 | BLK | 1.26912574 |
28 | PKN2 | 1.25928346 |
29 | CSK | 1.25074161 |
30 | FES | 1.24650430 |
31 | FGFR4 | 1.22017416 |
32 | GRK6 | 1.21563489 |
33 | TBK1 | 1.17334101 |
34 | PRKD2 | 1.15294074 |
35 | EPHB1 | 1.13376192 |
36 | RIPK1 | 1.12661463 |
37 | MAP3K1 | 1.11689456 |
38 | BTK | 1.11451739 |
39 | JAK3 | 1.09842698 |
40 | MAP3K3 | 1.06163800 |
41 | LRRK2 | 1.05017428 |
42 | RPS6KL1 | 1.04167357 |
43 | RPS6KC1 | 1.04167357 |
44 | KSR2 | 0.98851715 |
45 | TESK1 | 0.96603302 |
46 | HIPK2 | 0.92365253 |
47 | CDC42BPA | 0.92343261 |
48 | MAP2K2 | 0.90789995 |
49 | PIM2 | 0.89766835 |
50 | SIK3 | 0.89693371 |
51 | PTK6 | 0.89646131 |
52 | RPS6KA2 | 0.88654498 |
53 | MAP3K14 | 0.87532771 |
54 | BRAF | 0.86737377 |
55 | TTN | 0.86519616 |
56 | HCK | 0.85177872 |
57 | RPS6KA6 | 0.83041789 |
58 | IRAK2 | 0.83006734 |
59 | MTOR | 0.81132007 |
60 | CDK4 | 0.78232619 |
61 | PDPK1 | 0.76904063 |
62 | TYRO3 | 0.75242786 |
63 | MAPK12 | 0.70156357 |
64 | MAPK11 | 0.69558663 |
65 | DYRK1B | 0.65891150 |
66 | MARK3 | 0.65154380 |
67 | MAP3K8 | 0.64026145 |
68 | SYK | 0.63864804 |
69 | IKBKB | 0.61932658 |
70 | RET | 0.60702813 |
71 | IKBKE | 0.58916994 |
72 | PDK1 | 0.56706184 |
73 | CSF1R | 0.56608685 |
74 | CAMKK1 | 0.56534416 |
75 | LCK | 0.55701336 |
76 | PRKD3 | 0.55062190 |
77 | BMX | 0.54728544 |
78 | MAPK7 | 0.54035150 |
79 | MAPK4 | 0.50553596 |
80 | CDK9 | 0.50384289 |
81 | MOS | 0.48665917 |
82 | LYN | 0.48535624 |
83 | JAK1 | 0.47375664 |
84 | MAP3K9 | 0.47363001 |
85 | MAP3K7 | 0.46164350 |
86 | JAK2 | 0.44267096 |
87 | PDGFRA | 0.43820769 |
88 | CDK7 | 0.42936404 |
89 | MATK | 0.41035593 |
90 | RPS6KA1 | 0.39879232 |
91 | RAF1 | 0.37246800 |
92 | FGFR3 | 0.37153832 |
93 | MAPKAPK2 | 0.37007970 |
94 | FGR | 0.36762634 |
95 | MAP3K6 | 0.36306047 |
96 | STK38 | 0.34266315 |
97 | PIM1 | 0.34141930 |
98 | STK10 | 0.33435587 |
99 | ABL2 | 0.32855503 |
100 | RPS6KB2 | 0.31453676 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.67327076 |
2 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.59243889 |
3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.45538305 |
4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.23447578 |
5 | Notch signaling pathway_Homo sapiens_hsa04330 | 2.18286191 |
6 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 2.07544522 |
7 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 2.01128833 |
8 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.97004403 |
9 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.90489828 |
10 | Leishmaniasis_Homo sapiens_hsa05140 | 1.81961351 |
11 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.80781781 |
12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.74324849 |
13 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.73270784 |
14 | Endometrial cancer_Homo sapiens_hsa05213 | 1.60357026 |
15 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.60324690 |
16 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.59822302 |
17 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.46581091 |
18 | Hepatitis B_Homo sapiens_hsa05161 | 1.41925363 |
19 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.36698882 |
20 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.33907098 |
21 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.32067545 |
22 | Tuberculosis_Homo sapiens_hsa05152 | 1.29710465 |
23 | Bladder cancer_Homo sapiens_hsa05219 | 1.28636594 |
24 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.28535857 |
25 | Measles_Homo sapiens_hsa05162 | 1.25295641 |
26 | Influenza A_Homo sapiens_hsa05164 | 1.24034490 |
27 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.22712873 |
28 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.22299359 |
29 | Colorectal cancer_Homo sapiens_hsa05210 | 1.21914020 |
30 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.21899082 |
31 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.20076528 |
32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.19397692 |
33 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.18837943 |
34 | Hepatitis C_Homo sapiens_hsa05160 | 1.18666971 |
35 | Sulfur relay system_Homo sapiens_hsa04122 | 1.18657715 |
36 | Thyroid cancer_Homo sapiens_hsa05216 | 1.17454639 |
37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.15582573 |
38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.13420218 |
39 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.09735426 |
40 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.09264690 |
41 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.09198717 |
42 | Viral myocarditis_Homo sapiens_hsa05416 | 1.08651444 |
43 | Apoptosis_Homo sapiens_hsa04210 | 1.07223297 |
44 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.06923493 |
45 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.06286461 |
46 | Prion diseases_Homo sapiens_hsa05020 | 1.06038163 |
47 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.04799096 |
48 | Malaria_Homo sapiens_hsa05144 | 1.02175584 |
49 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.01722974 |
50 | HTLV-I infection_Homo sapiens_hsa05166 | 1.00134758 |
51 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.98181024 |
52 | Allograft rejection_Homo sapiens_hsa05330 | 0.95898458 |
53 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.95573057 |
54 | Lysosome_Homo sapiens_hsa04142 | 0.95154261 |
55 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.93912058 |
56 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.93134078 |
57 | Glioma_Homo sapiens_hsa05214 | 0.92873375 |
58 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.92653330 |
59 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.92003115 |
60 | Ribosome_Homo sapiens_hsa03010 | 0.91946352 |
61 | Prostate cancer_Homo sapiens_hsa05215 | 0.91730087 |
62 | Shigellosis_Homo sapiens_hsa05131 | 0.91083856 |
63 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.91059516 |
64 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.89462160 |
65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.89411140 |
66 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.88911034 |
67 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.88499611 |
68 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.86682171 |
69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.86607562 |
70 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.86051772 |
71 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.85992814 |
72 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.85807572 |
73 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.85255841 |
74 | Endocytosis_Homo sapiens_hsa04144 | 0.85053905 |
75 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.83730722 |
76 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.80239564 |
77 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.79250020 |
78 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.77848573 |
79 | Platelet activation_Homo sapiens_hsa04611 | 0.77807585 |
80 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.72729858 |
81 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.72357187 |
82 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.70469307 |
83 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.68590066 |
84 | Phagosome_Homo sapiens_hsa04145 | 0.68321382 |
85 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67792105 |
86 | Insulin resistance_Homo sapiens_hsa04931 | 0.65785473 |
87 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.64666187 |
88 | Salmonella infection_Homo sapiens_hsa05132 | 0.63573062 |
89 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.63266474 |
90 | Amoebiasis_Homo sapiens_hsa05146 | 0.62115071 |
91 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.61501164 |
92 | Base excision repair_Homo sapiens_hsa03410 | 0.61368986 |
93 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.59855468 |
94 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.58088191 |
95 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56721842 |
96 | Pertussis_Homo sapiens_hsa05133 | 0.54251553 |
97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.53313903 |
98 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50899147 |
99 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.50789845 |
100 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.49770200 |